These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1125731)

  • 1. Slow release potassium chloride treatment.
    Howie AD; Strachan RW
    Br Med J; 1975 Apr; 2(5964):176. PubMed ID: 1125731
    [No Abstract]   [Full Text] [Related]  

  • 2. Perforation of small bowel due to slow release potassium chloride (slow-K).
    Farquharson-Roberts MA; Giddings AE; Nunn AJ
    Br Med J; 1975 Jul; 3(5977):206. PubMed ID: 1148734
    [No Abstract]   [Full Text] [Related]  

  • 3. Controlled-release potassium supplementation.
    Tarpley EL
    Curr Ther Res Clin Exp; 1974 Jul; 16(7):734-41. PubMed ID: 4210463
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacology update: slow-release potassium chloride supplements.
    Romankiewicz N
    J Pract Nurs; 1983; 33(7):7-8. PubMed ID: 6555240
    [No Abstract]   [Full Text] [Related]  

  • 5. Dysphagia caused by cardiac enlargement.
    Whitney B; Croxon R
    Clin Radiol; 1972 Apr; 23(2):147-52. PubMed ID: 4263165
    [No Abstract]   [Full Text] [Related]  

  • 6. Dysphagia after open heart surgery.
    Boyce HW
    Hosp Pract (Off Ed); 1985 Sep; 20(9):40, 43, 47 passim. PubMed ID: 3928644
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect on plasma potassium of a combined preparation of frusemide and slow-release potassium chloride (Diumide-K Continus tablets).
    Lewis JG
    J Int Med Res; 1979; 7(5):354-9. PubMed ID: 499643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of a new potassium chloride delayed-action preparation in cardiopathy patients].
    Tronconi L; Recusani F; Sgalambro A; Raisaro A; Chinea B
    Clin Ter; 1982 Aug; 102(4):369-77. PubMed ID: 7140187
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparison of two commercial potassium chloride tablets for slow-release in an in vitro dissolution test].
    Wu PC; Huang YB; Chang SJ; Ko HM; Tsai YH
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1992 Mar; 8(3):161-7. PubMed ID: 1560473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Klotrix and other slow-release potassium tablets.
    Med Lett Drugs Ther; 1981 Jan; 23(1):3-4. PubMed ID: 7453668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypokalemia, potassium loss and liver cirrhosis. Value of potassium chloride sustained-release tablets].
    Lévy VG; Caroli J
    Therapeutique; 1971 Dec; 47(10):845-51. PubMed ID: 5145546
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics and effects on fecal blood loss of a controlled release potassium chloride tablet.
    Tannen RL; Cordano A
    J Pharmacol Exp Ther; 1978 Jan; 204(1):240-6. PubMed ID: 304099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro biopharmaceutical control of drugs. 3. Comparative study of delayed-release potassium chloride-containing oral preparations].
    Keserü P; Szalai H; Paál T
    Acta Pharm Hung; 1982 Jul; 52(4):163-70. PubMed ID: 7170979
    [No Abstract]   [Full Text] [Related]  

  • 14. Gut lesions due to slow-release KCl tablets.
    N Engl J Med; 1977 Jan; 296(2):111-2. PubMed ID: 830293
    [No Abstract]   [Full Text] [Related]  

  • 15. Ulceration and stricture of the esophagus due to oral potassium chloride (slow release tablet) therapy.
    Lambert JR; Newman A
    Am J Gastroenterol; 1980 Jun; 73(6):508-11. PubMed ID: 7424872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical studies of a sustained-release potassium salt preparation].
    Nukada T
    Nihon Rinsho; 1977 Dec; 35(12):4305-9. PubMed ID: 342763
    [No Abstract]   [Full Text] [Related]  

  • 17. Sustained release tablets for potassium chloride administration. A pharmacological study.
    Bervenmark H; Eriksson G; Ljungberg S; Paalzow L
    Acta Pharm Suec; 1966 Feb; 3(1):45-58. PubMed ID: 5909431
    [No Abstract]   [Full Text] [Related]  

  • 18. Potassium Chloride Sustained Release Dosing Pathway in an Academic Medical Center.
    Cook BM; Carter DM; Dell'Orfano H; Matta L
    Crit Pathw Cardiol; 2017 Dec; 16(4):158-160. PubMed ID: 29135624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vivo and in vitro studies of the release of active ingredients in solid oral pharmaceutical preparations containing potassium chloride].
    Ekes G; Szentmiklósi P; Rácz I; Mezei J; Küttel S; Jancsó S
    Acta Pharm Hung; 1985 Sep; 55(5):163-7. PubMed ID: 4061085
    [No Abstract]   [Full Text] [Related]  

  • 20. [Bioavailability of potassium chloride from delayed-action preparations].
    Holzgreve H; Stephan R
    Med Welt; 1978 Oct; 29(43):1702-6. PubMed ID: 713790
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.